Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Epinephrin, Atc C01ca24 For The Time 01.07.2025 - 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-15
Germany Open House Medicinal Department Treaties For The Active Ingredient Diclofenac, Topical Dosage Forms, Atc D11ax18 2025-11-15
Germany Completion Not Excl. Pharmaceutical Discount Club. According To Section 130a (8) Sgb V By An Open House Model To The Active Ingredient Liraglutide (atc Code According To Who: A10bj02; Official Atc: A10bj02) 2025-11-15
Germany Open House Pharmaceutical Dact Treaties For The Active Ingredient Denosumab, Trade Name Xgeva, Atc M05bx04 2025-11-15
Germany Open House Pharmaceutical Dact Treaties To The Active Ingredient Leuprorelin, Atc L02ae02, H01ca04 2025-11-15
Germany Completion Not Excl. Pharmaceutical Discount Club.according To Section 130a (8) Sgb V By An Open House Model To The Active Ingredient Liraglutide (atc Code According To Who: A10bj02; Official Atc: A10bj02) 2025-11-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Epinephrin, Atc C01ca24 For The Time 01.07.2025 - 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-15
Germany Open House Drug Discount Contracts Iron(iii) Hydroxide Polymaltose Complex, Atc B03ac01 2025-11-15
Austria Market Exploration "analysis Systems For Blood Count + Crp" 2025-11-15
Finland Request / Anesthesia Machines 2025-11-15
Whats app